Our Publications

2018

Building Kidney Exchange Programmes in Europe - An Overview of Exchange Practice and Activities. Biró P, Haase-Kromwijk B, Andersson T, Ásgeirsson EI, Baltesová T, Boletis I, Bolotinha C, Bond G, Böhmig G, Burnapp L, Cechlárová K, Di Ciaccio P, Fronek J, Hadaya K, Hemke A, Jacquelinet C, Johnson R, Kieszek R, Kuypers D, Leishman R, Macher MA, Manlove D, Menoudakou G, Salonen M, Smeulders B, Sparacino V, Spieksma F, de la Oliva Valentín Muñoz M, Wilson N, Vd Klundert J; ENCKEP COST Action. Transplantation, in press.

Novel Approaches to Block Complement.
Böhmig GA, Wahrmann M, Eskandary F, Rostaing L. Transplantation, 2018 Nov;102(11):1837-1843.

Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients. Strassl R, Schiemann M, Doberer K, Görzer I, Puchhammer-Stöckl E, Eskandary F, Kikic Ž, Gualdoni GA, Vossen MG, Rasoul-Rockenschaub S, Herkner H, Böhmig GA, Bond G. J Infect Dis, 2018 Sep 8;218(8):1191-1199.

An integrative approach for the assessment of peritubular capillaritis extent and score in low-grade microvascular inflammation-associations with transplant glomerulopathy and graft loss. Kozakowski N, Herkner H, Eskandary F, Eder M, Winnicki W, Kläger J, Bond G, Kikic Ž. Nephrol Dial Transplant, in press

Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation. Arnold ML, Kainz A, Hidalgo LG, Eskandary F, Kozakowski N, Wahrmann M, Haslacher H, Oberbauer R, Heilos A, Spriewald BM, Halloran PF, Böhmig GA. Am J Transplant, 2018 Sep;18(9):2261-2273.

Single antigen bead assays to define unacceptable antigen mismatches?
Böhmig GA, Hidalgo LG. Transplantation, 2018 Jun;102(6):894-895.

Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial. Eskandary F, Jilma B, Mühlbacher J, Wahrmann M, Regele H, Kozakowski N, Firbas C, Panicker S, Parry GC, Gilbert JC, Halloran PF, Böhmig GA. Am J Transplant. 2018 Apr;18(4):916-926.

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection. Eskandary F, Regele H, Baumann L, Bond G, Kozakowski N, Wahrmann M, Hidalgo LG, Haslacher H, Kaltenecker CC, Aretin MB, Oberbauer R, Posch M, Staudenherz A, Handisurya A, Reeve J, Halloran PF, Böhmig GA. J Am Soc Nephrol. 2018 Feb;29(2):591-605.

 

2017

Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study. Halloran PF, Reeve J, Akalin E, Aubert O, Böhmig GA, Brennan D, Bromberg G, Einecke G, Eskandary F, Gosset C, Duong Van Huyen JP, Gupta G, Lefaucheur C, Malone A, Mannon RB, Seron D, Sellares J, Weir M, Loupy A. Am J Transplantation. 2017 Nov;17(11):2851-2862.

Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetes. Kuessel L, Herkner H, Wahrmann M, Eskandary F, Doberer K, Binder J, Pateisky P, Zeisler H, Böhmig GA, Bond G. Scientific Reports. 2017 Oct 19;7(1):13524.

Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera from Subjects Dosed with the Anti-C1s Monoclonal Antibody TNT009 - Results from a Randomized First-in-Human Phase 1 Trial. Mühlbacher J, Jilma B, Wahrmann M, Bartko J, Eskandary F, Schörgenhofer C, Schwameis M, Parry GC, Gilbert JC, Panicker S, Böhmig GA. Transplantation. 2017 Oct;101(10):2410-2418.

Effect of the Anti-C1s Humanized Antibody TNT009 and its Parental Mouse Variant TNT003 on HLA Antibody-induced Complement Activation - A Preclinical in Vitro Study. Wahrmann M, Mühlbacher J, Marinova L, Regele H, Huttary N, Eskandary F, Cohen G, Fischer GF, Parry GC, Gilbert JC, Panicker S, Böhmig GA. Am J Transplant. 2017 Sep;17(9):2300-2311.

The Effect of Cortex/Medulla Proportions on Molecular Diagnoses in Kidney Transplant Biopsies: Rejection and Injury Can Be Assessed in Medulla. Madill-Thomsen KS, Wiggins RC, Eskandary F, Böhmig GA, Halloran PF. Am J Transplant. 2017 Aug;17(8):2117-2128.

Czech-Austrian kidney paired donation: first European cross-border living donor kidney exchange. Böhmig GA, Fronek J, Slavcev A, Fischer GF, Berlakovich G, Viklicky O. Transpl Int. 2017 Jun;30(6):638-639.

Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes. Reeve J, Böhmig GA, Eskandary F, Einecke G, Lefaucheur C, Loupy A, Halloran PF; MMDx-Kidney study group. JCI Insight. 2017 Jun 15;2(12).

Diffuse Extent of Peritubular Capillaritis in Late Antibody-mediated Rejection: Associations With Levels of Donor-specific Antibodies and Chronic Allograft Injury. Kozakowski N, Eskandary F, Herkner H, Bond G, Oberbauer R, Regele H, Böhmig GA, Kikić Ž. Transplantation. 2017 May;101(5):e178-e187.

Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study. Eskandary F, Bond G, Kozakowski N, Regele H, Marinova L, Wahrmann M, Kikić Ž, Haslacher H, Rasoul-Rockenschaub S, Kaltenecker CC, König F, Hidalgo LG, Oberbauer R, Halloran PF, Böhmig GA. Transplantation. 2017 Mar;101(3):631-641.

Torque Teno Virus Load-Inverse Association With Antibody-Mediated Rejection After Kidney Transplantation.
Schiemann M, Puchhammer-Stöckl E, Eskandary F, Kohlbeck P, Rasoul-Rockenschaub S, Heilos A, Kozakowski N, Görzer I, Kikić Ž, Herkner H, Böhmig GA, Bond G. Transplantation. 2017 Feb;101(2):360-367.
 

2016

Combined integrated protocol/basket trial design for a first-in-human trial. Derhaschnig U, Gilbert J, Jäger U, Böhmig G, Stingl G, Jilma B. Orphanet J Rare Dis. 2016 Oct 4;11(1):134.

Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection. Schwaiger E, Eskandary F, Kozakowski N, Bond G, Kikić Ž, Yoo D, Rasoul-Rockenschaub S, Oberbauer R, Böhmig GA. Nephrol Dial Transplant. 2016 Aug;31(8):1342-51.

Ig-like transcript 4 as a cellular receptor for soluble complement fragment C4d. Hofer J, Forster F, Isenman DE, Wahrmann M, Leitner J, Hölzl MA, Kovarik JJ, Stockinger H, Böhmig GA, Steinberger P, Zlabinger GJ. FASEB J. 2016 Apr;30(4):1492-503.

Complement inhibition as potential new therapy for antibody-mediated rejection. Eskandary F, Wahrmann M, Mühlbacher J, Böhmig GA. Transpl Int. 2016 Apr;29(4):392-402.

Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection? Böhmig GA, Kikic Z, Wahrmann M, Eskandary F, Aliabadi AZ, Zlabinger GJ, Regele H, Feucht HE. Clin Biochem. 2016 Mar;49(4-5):394-403.

Effect of combined treatment with immunoadsorption and membrane filtration on plasma coagulation--Results of a randomized controlled crossover study. Biesenbach P, Eskandary F, Ay C, Wiegele M, Derfler K, Schaden E, Haslacher H, Oberbauer R, Böhmig GA. J Clin Apher. 2016 Feb;31(1):29-37.

 

2015

Strategies to overcome the ABO barrier in kidney transplantation. Böhmig GA, Farkas AM, Eskandary F, Wekerle T. Nat Rev Nephrol. 2015 Dec;11(12):732-47.

The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss. Kozakowski N, Herkner H, Böhmig GA, Regele H, Kornauth C, Bond G, Kikić Ž. Kidney Int. 2015 Aug;88(2):332-40.

Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection. Kikić Ž, Kainz A, Kozakowski N, Oberbauer R, Regele H, Bond G, Böhmig GA. Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1435-43.

Long-term outcome of belatacept therapy in de novo kidney transplant recipients - a case match analysis. Schwarz C, Mayerhoffer S, Berlakovich G, Steininger R, Soliman T, Watschinger B, Böhmig G, Eskandary F, König F, Mühlbacher F, Wekerle T. Transplant International. 2015 July; 28(7):820-7

Surface Plasmon Resonance Analysis Shows an IgG-Isotype-Specific Defect in ABO Blood Group Antibody Formation in Patients with Common Variable Immunodeficiency. Fischer MB, Wolfram W, Binder CJ, Böhmig GA, Wahrmann M, Eibl MM, Wolf HM. Front Immunol. 2015 May 6;6:211.

Kinetics of mast cell migration during transplantation tolerance.Bond G, Nowocin A, Sacks SH, Wong W. Transpl Immunol. 2015 Jan;32(1):40-5.

 

2014

Kidney paired donation. Combination with extracorporeal desensitization. Bond G, Böhmig GA. Med Klin Intensivmed Notfmed. 2014 Sep;109(6):408-10.

Antibody-mediated rejection: analyzing the risk, proposing solutions. Arias M, Rush DN, Wiebe C, Gibson IW, Blydt-Hansen TD, Nickerson PW, Sellarés J, López-Hoyos M, San Segundo D, Crespo-Leiro MG, Marzoa-Rivas R, Barge-Caballero E, Paniagua-Martín MJ, Román A, Serón D, Böhmig G, Schwaiger E. Transplantation. 2014 Aug 15;98 Suppl 3:S3-21.

Rejection despite C5 blockade: a distinct role of IgM? Böhmig GA, Eskandary F. Transpl Int. 2014 Dec;27(12):1233-4.

Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial.Eskandary F, Bond G, Schwaiger E, Kikic Z, Winzer C, Wahrmann M, Marinova L, Haslacher H, Regele H, Oberbauer R, Böhmig GA. Trials. 2014 Apr 3;15:107.

Complement component C3 activation: the leading cause of the prozone phenomenon affecting HLA antibody detection on single-antigen beads. Schwaiger E, Wahrmann M, Bond G, Eskandary F, Böhmig GA. Transplantation. 2014 Jun 27;97(12):1279-85.

Lack of donor and recipient age interaction in cardiac transplantation. Eskandary FA, Kohl M, Dunkler D, Aliabadi A, Grömmer M, Schiferer A, Gökler J, Wieselthaler G, Laufer G, Zuckermann A. J Heart Lung Transplant. 2014 Jun;33(6):629-35.

ABO antibody and complement depletion by immunoadsorption combined with membrane filtration--a randomized, controlled, cross-over trial. Eskandary F, Wahrmann M, Biesenbach P, Sandurkov C, König F, Schwaiger E, Perkmann T, Künig S, Derfler K, Zlabinger GJ, Böhmig GA. Nephrol Dial Transplant. 2014 Mar;29(3):706-14.

Clinicopathological relevance of granular C4d deposition in peritubular capillaries of kidney allografts. Kikić Z, Kozakowski N, Regele H, Priessner K, Nordmeyer V, Marinova L, Zlabinger GJ, Wahrmann M, Bartel G, Böhmig GA. Transpl Int. 2014 Mar;27(3):312-21.

Pretransplant risk stratification for early survival of renal allograft recipients. Kikić Z, Herkner H, Sengölge G, Kozakowski N, Bartel G, Plischke M. Eur J Clin Invest. 2014 Feb;44(2):168-75.

Late antibody-mediated rejection in a large prospective cross-sectional cohort of kidney allograft recipients - preliminary results of the screening phase of the BORTEJECT study. Eskandary FA, Bond G, Regele H, Kozakowski N, Kikić Z, Wahrmann M, Haslacher H, Oberbauer R, Ramassar V, Halloran PF, and Böhmig GA. Clinical Transplants. 2014: 189-95.

 

2013

Transnational validation of the Australian algorithm for virtual crossmatch allocation in kidney paired donation. Böhmig GA, Fidler S, Christiansen FT, Fischer G, Ferrari P. Hum Immunol. 2013 May;74(5):500-5.

Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients. Bartel G, Wahrmann M, Schwaiger E, Kikić Ž, Winzer C, Hörl WH, Mühlbacher F, Hoke M, Zlabinger GJ, Regele H, Böhmig GA. Transpl Int. 2013 Feb;26(2):121-30.

Modified solid-phase alloantibody detection for improved crossmatch prediction. Wahrmann M, Hlavin G, Fischer G, Marinova L, Schwaiger E, Hörl WH, Zlabinger GJ, Körmöczi GF, König F, Böhmig GA. Hum Immunol. 2013 Jan;74(1):32-40.

Donor specific transplant tolerance is dependent on complement receptors. Bartel G, Brown K, Phillips R, Peng Q, Zhou W, Sacks SH, Wong W. Transpl Int. 2013 Jan;26(1):99-108.

 

2012

Impact of live-donor exchange on transplant waiting time. Böhmig GA. Transpl Int. 2012 Oct;25(10):1024-5.

Special focus--Antibody-mediated rejection. Guest editorial. Böhmig GA, Derfler K. Transpl Int. 2012 Jun;25(6):603.

Anti-A/B antibody depletion by semiselective versus ABO blood group-specific immunoadsorption.Wahrmann M, Schiemann M, Marinova L, Körmöczi GF, Derfler K, Fehr T, Stussi G, Böhmig GA. Nephrol Dial Transplant. 2012 May;27(5):2122-9.

 

2011

Transplantation of the broadly sensitized patient: what are the options? Böhmig GA, Wahrmann M, Bartel G. Curr Opin Organ Transplant. 2011 Dec;16(6):588-93.

Prevention and treatment of alloantibody-mediated kidney transplant rejection. Bartel G, Schwaiger E, Böhmig GA. Transpl Int. 2011 Dec;24(12):1142-55.

Desensitization and crossmatch conversion in deceased donor kidney transplantation. Bartel G, Böhmig GA. Minerva Urol Nefrol. 2011 Mar;63(1):21-34.

Genotypic diversity of complement component C4 does not predict kidney transplant outcome. Wahrmann M, Döhler B, Ruhenstroth A, Haslacher H, Perkmann T, Exner M, Rees AJ, Böhmig GA. J Am Soc Nephrol. 2011 Feb;22(2):367-76.

Significance of peritubular capillary, glomerular, and arteriolar C4d staining patterns in paraffin sections of early kidney transplant biopsies. Kikić Z, Regele H, Nordmeyer V, Wahrmann M, Kletzmayr J, Bartel G, Böhmig GA. Transplantation. 2011 Feb 27;91(4):440-6.

Prevalence and qualitative properties of circulating anti-human leukocyte antigen alloantibodies after pregnancy: no association with unexplained recurrent miscarriage. Bartel G, Walch K, Wahrmann M, Pils S, Küssel L, Polterauer S, Tempfer C, Böhmig GA. Hum Immunol. 2011 Feb;72(2):187-92.

 

2010

Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation.Bartel G, Wahrmann M, Regele H, Kikić Z, Fischer G, Druml W, Mühlbacher F, Böhmig GA. Am J Transplant. 2010 Sep;10(9):2033-42.

Effect of the proteasome inhibitor bortezomib on humoral immunity in two presensitized renal transplant candidates. Wahrmann M, Haidinger M, Körmöczi GF, Weichhart T, Säemann MD, Geyeregger R, Kikić Z, Prikoszovich T, Drach J, Böhmig GA. Transplantation. 2010 Jun 15;89(11):1385-90.

Detecting adaptive immunity: applications in transplantation monitoring. Böhmig GA, Wahrmann M, Säemann MD. Mol Diagn Ther. 2010 Feb 1;14(1):1-11.

 

2009

Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report. Schwaiger E, Regele H, Wahrmann M, Werzowa J, Haidbauer B, Schmidt A, Böhmig GA. Clin Transpl. 2010:391-6.

Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials.Kikić Z, Lorenz M, Sunder-Plassmann G, Schillinger M, Regele H, Györi G, Mühlbacher F, Winkelmayer WC, Böhmig GA. Transplantation. 2009 Dec 27;88(12):1377-85.

Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients. Wahrmann M, Bartel G, Exner M, Regele H, Körmöczi GF, Fischer GF, Böhmig GA. Transpl Int. 2009 Oct;22(10):982-9.

Monocytes/macrophages in kidney allograft intimal arteritis: no association with markers of humoral rejection or with inferior outcome. Kozakowski N, Böhmig GA, Exner M, Soleiman A, Huttary N, Nagy-Bojarszky K, Ecker RC, Kikić Z, Regele H. Nephrol Dial Transplant. 2009 Jun;24(6):1979-86. 

Vienna experience of ABO-incompatible living-donor kidney transplantation. Haidinger M, Schmaldienst S, Körmöczi G, Regele H, Soleiman A, Schwartz D, Derfler K, Steininger R, Mühlbacher F, Böhmig GA. Wien Klin Wochenschr. 2009;121(7-8):247-55.

Proteasome inhibition for recipient desensitization? A report of two sensitized kidney transplant candidates subjected to bortezomib treatment. Wahrmann M, Haidinger M, Drach J, Geyeregger R, Kikić Z, Raab R, Säemann MD, Böhmig GA. Clin Transpl. 2009:415-20.

 

2008

Posttransplant HLA alloreactivity in stable kidney transplant recipients-incidences and impact on long-term allograft outcomes. Bartel G, Regele H, Wahrmann M, Huttary N, Exner M, Hörl WH, Böhmig GA. Am J Transplant. 2008 Dec;8(12):2652-60.

Antibodies, isotypes and complement in allograft rejection. Böhmig GA, Bartel G, Wahrmann M. Curr Opin Organ Transplant. 2008 Aug;13(4):411-8.

In vitro detection of C4d-fixing HLA alloantibodies: associations with capillary C4d deposition in kidney allografts.Bartel G, Wahrmann M, Exner M, Regele H, Huttary N, Schillinger M, Körmöczi GF, Hörl WH, Böhmig GA. Am J Transplant. 2008 Jan;8(1):41-9.

 

2007

Determinants of the complement-fixing ability of recipient presensitization against HLA antigens. Bartel G, Wahrmann M, Exner M, Regele H, Schillinger M, Hörl WH, Böhmig GA. Transplantation. 2007 Mar 27;83(6):727-33.

Imunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial. Böhmig GA, Wahrmann M, Regele H, Exner M, Robl B, Derfler K, Soliman T, Bauer P, Müllner M, Druml W. Am J Transplant. 2007 Jan;7(1):117-21.

 

2006

Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.Schwarz C, Regele H, Huttary N, Wahrmann M, Exner M, Nagy-Bojarsky K, Kletzmayr J, Hörl WH, Böhmig GA. Wien Klin Wochenschr. 2006 Jul;118(13-14):397-404.

Alloantibodies-mediated kidney transplant rejection: a pair of continuing approaches, and with nonetheless many open questions. Böhmig G. Wien Klin Wochenschr. 2006 Jul;118(13-14):373-81.

Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients. Wahrmann M, Exner M, Schillinger M, Haidbauer B, Regele H, Körmöczi GF, Hörl WH, Böhmig GA. Am J Transplant. 2006 May;6(5 Pt 1):1033-41.

 

2005

[C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.Wahrmann M, Exner M, Haidbauer B, Schillinger M, Regele H, Körmöczi G, Böhmig GA. Hum Immunol. 2005 May;66(5):526-34.

Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients. Lorenz M, Regele H, Schillinger M, Kletzmayr J, Haidbauer B, Derfler K, Druml W, Böhmig GA. Transplantation. 2005 Mar 27;79(6):696-701.

Protocol biopsies after kidney transplantation. Böhmig GA, Regele H, Hörl WH. Transpl Int. 2005 Feb;18(2):131-9.

 

2004

Risk factors for capillary C4d deposition in kidney allografts: evaluation of a large study cohort. Lorenz M, Regele H, Schillinger M, Exner M, Rasoul-Rockenschaub S, Wahrmann M, Kletzmayr J, Silberhumer G, Hörl WH, Böhmig GA. Transplantation. 2004 Aug 15;78(3):447-52.

Diagnosis and treatment of antibody-mediated kidney allograft rejection. Böhmig G, Regele H. Transpl Int. 2003 Nov;16(11):773-87.

 

2003

Tissue injury and repair in allografts: novel perspectives. Regele H, Böhmig GA. Curr Opin Nephrol Hypertens. 2003 May;12(3):259-66.

Flow cytometry based detection of HLA alloantibody mediated classical complement activation. Wahrmann M, Exner M, Regele H, Derfler K, Körmöczi GF, Lhotta K, Zlabinger GJ, Böhmig GA. J Immunol Methods. 2003 Apr 1;275(1-2):149-60.

 

2002

A case of severe C4d-positive kidney allograft dysfunction in the absence of histomorphologic features of rejection. Habicht A, Regele H, Exner M, Soleiman A, Hörl WH, Watschinger B, Derfler K, Böhmig GA. Wien Klin Wochenschr. 2002 Nov 30;114(21-22):945-8.

Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. Böhmig GA, Exner M, Habicht A, Schillinger M, Lang U, Kletzmayr J, Säemann MD, Hörl WH, Watschinger B, Regele H. J Am Soc Nephrol. 2002 Apr;13(4):1091-9.

Acute humoral renal allograft rejection. Böhmig GA, Exner M, Watschinger B, Regele H. Curr Opin Urol. 2002 Mar;12(2):95-9.

 

2001

C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. Böhmig GA, Regele H, Exner M, Derhartunian V, Kletzmayr J, Säemann MD, Hörl WH, Druml W, Watschinger B. J Am Soc Nephrol. 2001 Nov;12(11):2482-9.

Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection.Regele H, Exner M, Watschinger B, Wenter C, Wahrmann M, Osterreicher C, Säemann MD, Mersich N, Hörl WH, Zlabinger GJ, Böhmig GA. Nephrol Dial Transplant. 2001 Oct;16(10):2058-66.

C4d deposits in renal allografts are associated with inferior graft outcome. Böhmig GA, Exner M, Watschinger B, Wenter C, Wahrmann M, Osterreicher C, Säemann MD, Mersich N, Hörl WH, Zlabinger GJ, Regele H. Transplant Proc. 2001 Feb-Mar;33(1-2):1151-2.